Commodore Capital
Venture capitalNew York · Series C–Late Stage · 16 people tracked
Find your way into Commodore Capital
1,756 people in our graph share verified history with the Commodore Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Commodore Capital believes the biopharmaceutical industry is in the early stages of a major innovation cycle, driven by scientific discoveries translating into clinical breakthroughs through novel therapeutic modalities such as genetic medicines and cellular therapies. The firm notes that innovation has shifted from large pharmaceutical companies to smaller biopharmaceutical firms. Commodore aims to be a supportive partner to these companies as they work to bring safe and effective new medicines to patients worldwide.
Source: firm website, verified Sep 1, 2026.
Team · 16 people
from the firm's website & curated & public directoriesWhat they invest in
from 2 of 2 portfolio companiesBiotech ×2Healthtech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro pathAgenus is a biotechnology company developing cancer immunotherapies, including its lead investigational combination of botensilimab (an anti-CTLA-4 antibody) and balstilimab (a PD-1 inhibitor), known as BOT+BAL.
BiotechHealthtechLexington, US
Garo Armen(Chairman & CEO, Co-founder)Ozer Baysal(Executive Officer)Robert Stein(Executive Officer)Christine Klaskin(Executive Officer)inKaren Valentine(Executive Officer)Steven O'Day(Chief Medical Officer)in
Co-investorsAdvent Life SciencesGrazia Equity GmbHHEALTHCARE ROYALTY PARTNERSOberland CapitalInvusLigand Pharmaceuticals+1 more
BiotechNew York, US
Sergio Traversa(Executive Officer, Director)Eliseo O. Salinas(President and Chief Scientific Officer)inDouglas Beck(Chief Financial Officer)Charles Casamento(Director)Paul Kelly(Director)Maged Shenouda(Director)
Co-investorsBioAdvanceBAM ElevateBraidwellJanus Henderson InvestorsOrbiMedRA Capital+2 more
Exits · 2
IPOs and acquisitions across the tracked portfolioAgenusNASDAQ: AGENRelmada TherapeuticsNASDAQ: RLMD
Portfolio news
latest coverage across their companiesAgenus · simplywall.st · Aug 15, 2026

Relmada Therapeutics · fool.com · Aug 14, 2026
Frequently asked questions
- What stage does Commodore Capital invest at?
- Commodore Capital invests at the Series C, Late Stage stages.
- What sectors does Commodore Capital focus on?
- Commodore Capital focuses on Biotech.
- Where is Commodore Capital located?
- Commodore Capital is headquartered in New York, US.
- Does Commodore Capital lead rounds?
- Commodore Capital typically participates in rounds rather than leading them.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.

















.jpeg)
